• Cathie Wood says Ark is testing a risky shorting strategy that would be like 'Ark on steroids'

    13 days ago - By Business Insider

    Photo by PATRICK T. FALLON/AFP via Getty Images Ark Invest is internally testing a new investment strategy that would be like "Ark on steroids." Cathie Wood told CNBC on Wednesday that the strategy would short companies that are being disrupted by new technologies. Wood said the strategy would be tested with its employees before it's launched for the public. A 15% year-to-date decline in Ark Invest's flagship Disruptive Innovation ETF isn't fazing Cathie Wood, who told CNBC on Wednesday that her firm is testing a new investment strategy that is like "Ark on steroids." The new portfolio...
    Read more ...